SyntekaBio Largest Shareholder Chung Jong-sun Partially Repays Pledged Loan Reducing Debt to 2.85 Billion Won, Control Risk Persists
SyntekaBio's largest shareholder Chung Jong-sun has revised his pledge agreement filing, reducing the loan amount from 3.15 billion won to 2.85 billion won due to partial repayment.
The collateral amount of 5.04 billion won and the number of pledged shares of 2.8 million remain unchanged.
If the collateral is fully executed, the largest shareholder's stake would drop from 14.36% to 2.82%, potentially triggering a change in management.
The contract period has been extended to July 28, 2026, and the default conditions for collateral execution remain.
[AI Summary]This amendment reflects a partial repayment of the largest shareholder's personal loan but does not significantly improve the overall risk profile. The large pledge still poses a potential dilution risk of over 11% and management instability, requiring investors to monitor further developments.
KOSDAQ Filing Information
[Correction of Description] Execution of Stock Pledge Agreement Involving Change of Largest Shareholder